Dr. Jerry J Lorio, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2010 Active Way, Benton, AR 72019 Phone: 501-315-0984 Fax: 501-847-1405 |
Dr. Mark S Bailey Jr., MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2010 Active Way, Benton, AR 72019 Phone: 501-315-0984 Fax: 501-847-1405 |
Jeffrey S Johnson, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2010 Active Way, Benton, AR 72022 Phone: 501-315-0984 Fax: 501-847-1405 |
Mr. Ralph D Cash, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2010 Active Way, Benton, AR 72019 Phone: 501-315-0984 Fax: 501-847-1405 |
Mr. Donald Scott Walsh, M.D, Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2010 Active Way, Benton, AR 72019 Phone: 501-315-0984 Fax: 501-847-1405 |
News Archive
Migraine and tension-type headaches may share genetic links with irritable bowel syndrome (IBS), according to a preliminary study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.
In the most recent development concerning Pressure Products' patent infringement case against Greatbatch Medical's valved, peelable introducer product line, The United States Court of Appeals for the Federal Circuit has affirmed the rulings of United States District Court for the Eastern District of Texas that Pressure Products' patents are valid and enforceable. In a split decision, the Federal Circuit remanded the case to the District Court for further proceedings concerning Greatbatch's infringement of Pressure Products' patents.
In an advance toward development of a nasal spray that protects against infection with influenza and spread of the disease, scientists are reporting identification of a substance that activates the first-line defense system against infection inside the nose. They describe effects of a synthetic form of a natural substance found in bacterial cell walls in ACS' journal Molecular Pharmaceutics.
Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.
Project Happiness, a 501(c)3 non-profit organization specializing in emotional resilience-building programs, announced today the launch of Hungry 4 Happiness, a viral grassroots fundraising campaign which combines a "chain" of dinner parties that will benefit Project Happiness through a platform that includes in-home promotion, social media outreach and blogger call-to-action.
› Verified 3 days ago